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Abstract  
The authors show a brief overview of the vitiligo’s unconventional therapies. A part for well-documented 
effectiveness of L-phenylalanine, PGE2 and antioxidant agents in the treatment of vitiligo, for the other 
therapeutical approaches more investigations are needed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
Despite the numerous therapies of proven 
efficacy available for vitiligo treatment, in the last 
decades new unconventional drugs had been 
introduced for the correction of cutaneous disease. 
The authors show a brief overview of the 
vitiligo’s unconventional therapies. 
 
Alpha Lipoic Acid 
Alpha lipoic acid is an organosulfur 
compound with important antioxidant properties. It is 
commonly found in many dietary products, such as 
tea, wine, beer, vegetable (e.g. broccoli, spinach), 
fruit and soy products [1]. Moreover, Alpha lipoic acid 
is found in yeast, kidney and liver. Recently, it is 
produced in laboratory for medical purpose. Alpha-
lipoic acid is used for the treatment of different 
disorders, such as diabetes, HIV/AIDS, cancer, liver 
and eye diseases, and others. It is generally 
administrated orally at various dosages, ranging 
from300 to 1,800 mg daily. 
Due to its antioxidant properties, recently, 
alpha-lipoic acid has been proposed in the treatment 
of vitiligo, to prevent the destruction of melanocytes by 
 Gianfaldoni et al. Unconventional Treatments for Vitiligo: Are They (Un)Satisfactory? 
_______________________________________________________________________________________________________________________________ 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2018 Jan 25; 6(1):170-175.                                                                                                                                                         171 
 
free radicals. It is generally used as adjuvant therapy 
in association to more conventional treatments (e.g. 
corticosteroids, phototherapy). Recent data underline 
its safe profile and effectiveness in terms of 
acceleration of cutaneous repigmentation in vitiligo 
patients [2][3). 
 
 
Flavonoids 
 
Flavonoids (also known as Bioflavonois) are 
polyphenolic compounds, with antioxidants, anti-
inflammatory and anti-microbial properties. They are 
widely found in plants and in many dietary products 
(e.g. wine, beer, tea, onions, blueberries, bananas, 
all citrus fruits, dark chocolate and others). 
Because their antioxidant action, flavonoids have 
been proposed as supplements in the treatment of 
vitiligo patients [4]. 
A particular mention is due to quercetin, a 
member of flavonoids, which has been evaluated, 
both in vitro and in vivo, for the treatment of the 
pigmentary disease [1]. Different studies underline 
how quercetin is able to protect keratinocytes and 
melanocytes by the oxidative damage, suggesting its 
effectiveness as adjuvant oral therapy in vitiliginous 
patients [5][6). Moreover, it has been observed how 
the topical application of quercetin may prevent 
ultraviolet radiation cellular damage [7]. 
 
 
Fluorouracil 
 
Fluorouracil (also known as 5-fluorouracil or 
5-FU) is a pyrimidine analog of the antimetabolites 
family, used in oncology for about 40 years, because 
of its anticancer properties. 
By some decades, it has been also used by 
dermatologist for the topical treatment of vitiligo [8]. 
The drug has been observed to be safe and effective 
in inducing repigmentation. Better results have been 
achieved in patients, who previously underwent to an 
epidermal abrasion (e.g. classical dermabrasion, 
cutaneous laser ablation), of skin lesions [9][10]. 
Recently, Capebetacina has been also 
proposed for vitiligo treatment. 
Capecitabine is an oral prodrug of 5-FU, used 
in the treatment of metastatic colon and breast 
cancers. It has been observed how its use cause 
cutaneous hyperpigmentation [11][12]. At the moment, 
more studies have to be conducted to evaluate the 
potential use of the drug in the treatment of vitiligo. 
 
Glutathione (GSH) 
 
Glutathione is a well-known antioxidant able 
to protect cellular components by oxidative stress 
damage. Recently, some studies underline how its 
oral use as supplement may be useful in preventing 
cells photo- damage [13][14]. Unfortunately, more 
data are needed for its potential use in the treatment 
of vitiligo. 
 
 
L-DOPA 
 
L-DOPA is an amino acid, normally produced 
from the amino acid L-tyrosine by the enzyme tyrosine 
hydroxylase. It is the precursor of some 
neurotransmitters (dopamine, noradrenaline and 
adrenaline), and of the melanin. 
In medicine, it is used in the clinical treatment 
of Parkinson's disease and dopamine-responsive 
dystonia. 
In seventies, by the description of 
neuromelanin loss from the substantia nigra in 
Parkinson’s patients, some authors hypotezed its 
potential use in vitiligo treatment. Unfortunately, only 
few cases reported its efficacy in vitiligo. First was 
Grainger who described the beard repigmentation in a 
Parkinson patient treated with L-DOPA [15]. 
Successively, Goolamali repoted the repigmentation 
of vitiliginous patients treated with levoDOPA plus UV 
lights [16]. In the same period, Woolfson et al treated 
16 patients, affected by vitiligo, with a topical 
preparation of L-DOPA 10% or 20% in a fatty 
alcohol/propylene glycol base. The results were 
unsatisfactory [17]. Since then, while no other 
studies confirmed the utility of the drug in therapy 
of the pigmentary disease, different studies underlined 
the role of L-DOPA in inducing vitiligo [18]. 
 
 
Levamisole 
 
Levamisole is an antihelminthic agent, which 
has been observed to have important 
immunoregulatory properties [19]. For this property, 
the drug has been used in the treatment of vitiligo. 
Few studies demonstrated how Levamisole may be 
considered as a valid and therapeutic tool, able to 
arrest the course of the disease and to induce 
repigmentation [20]. Even if the drug may be uses 
alone, the association with conventional therapies 
(e.g. corticosteroids) seems to be more effective [21]. 
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L-Phenylalanine 
 
L-Phenylalanine is an essential α-amino 
acid, which is used to biochemically form proteins, 
coded for by DNA. L-Phenylalanine is the natural 
precursor for tyrosine, which is further converted into 
cathecholamines (dopamine, noradrenaline and 
adrenaline) or in the cutaneous pigment melanin. L-
Phenylalanine may be introduced with dietary 
products (e.g. eggs, chicken, liver, beef, milk, cheese, 
soybeans) or nutritional supplements (e.g. 
aspartame), which are industrially produced by use of 
Escherichia coli, a bacterium able to produce large 
amount of phenylalanine and others amino acids 
[22]. The amino acid is usually safe, except for 
people affected by phenylketonuria, a rare genetic 
disorder charaterized by the inability to metabolize 
phenylalanine because of the lack of the enzime 
phenylalanine hydroxylase. 
L-Phenylalanine is widely used in medicine for 
the treatment of different diseases (e.g. depression, 
attention deficit-hyperactivity disorder, Parkinson's 
disease, chronic pain, osteoarthritis, rheumatoid 
arthritis). 
Because it is a precursor of melanin [23], 
dermatologists use the amino acids as a therapeutic 
tool for vitiligo treatments. 
L-Phenylalanine may be administrated both 
orally (50 – 100 mg/kg of body weight) or topically, 
and provide better results if combined with UV 
exposure. The oral administration of phenylalanine 
(50 – 100 mg/kg of body weight) combined with 
UVA exposure (also known as PAUVA) is well-
known therapy for vitiligo since long time. It is 
generally well-tolerate and provide quite good results 
in term of repigmentation rate [24]. Recently, a 
variant of the classic PAUVA has been 
experimented. It consists in the oral intake of 
khellin encapsulated in L-phenylalanin stabilized 
phosphatidylcholine liposomes, in combination with 
ultraviolet light therapy (both UVA and UVB). The 
treatment (also known as KPLUV) has been shown to 
be effective and safe for the treatment of vitiligo 
patients [25]. 
Different therapeutic options are based on the 
oral and topical application of L-Phenilalanin plus 
ultraviolet radiation, both natural (sol-therapy) or 
artificial (UVA or nb-UVB) [26]; and on the oral and 
topical L- phenylalanine, associated to local clobetasol 
propionate, and UVA/sunlight [27]. Both the protocols 
have provided good results in term of repigmentation. 
On the other hand, there is the possibility to 
treat vitiliginous patches with topical L-phenylalanine 
(cream with L-Phenylalanine 10%), alone, or better, in 
association with phototherapy/target phototherapy 
[28]. Finally a mention is due to the introduction of an 
innovative combined treatment, which is based on the 
topical application of a cream composed by 
phenylalanine, cucumis melo extract, and acetyl 
cysteine, followed by the irradiation with target nb-
UVB. The therapeutic protocol has been seen to be 
effective and safe for vitiligo treatment [29]. 
 
 
Melagenine 
 
Melagenine is an alcohol extract of human 
placenta, which has been proposed for the topical 
treatment of vitiligo patients [30]. Even if the exact 
mechanism of action is still unclear, it seems to 
stimulate the melanoblast and melanocyte 
proliferation and the melanogenesis [31]. Classically, 
it is applied twice a day, alone or in association with 
ultraviolet radiation. Interestingly, a pilot study 
underlines the effectiveness of topical melagenine in 
combination with 20 minutes of infrared exposure 
twice daily, in the repigmentation of scalp vitiligo [32]. 
Recently a new formulation of melagenine 
(Melagenina plus) has been formulated; it consists in 
a alcohol human placental extract with calcium. The 
drug is applied once a day, and seems to be effective 
in stimulating the repigmentation [33]. No side effects 
had been described in the use of both Melagenine 
and Melagenine plus. Unfortunately, no recent data 
are available on the use of melagenine in vitiligo. 
 
 
Metals 
 
Zinc is a metal, which has many vital 
functions in human, such as regulation of RNA and 
DNA metabolism, signal transduction, gene 
expression, cofactor for enzymes and antioxidant 
defense system, and cellular apoptosis [34]. It can 
be assumed with animal-sourced food (e.g. meat, 
fish, shellfish, fowl, eggs, dairy), food plants 
(sesame, poppy, mustard, beans, nuts, grains, 
pumpkin seeds, sunflower seeds and others) and 
dietary supplements. 
Recently, it has been proposed for vitiligo 
treatment, in association to conventional therapies, 
such as topical corticosteroid [35]. Unfortunately, the 
few data, which are today available, don’t support its 
efficacy in the treatment of the pigmentary disorder. 
 
 
Minoxidil 
 
Topical Minoxidil (2% or 5%) is a vasodilator 
drug, which is used topically to treat different forms of 
hair loss (e.g. male androgenetic alopecia, female 
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androgenetic alopecia, alopecia areata and other) 
[36]. Even if exact mechanism of action is not well 
understood, it seems possible that, by widening blood 
vessels, Minoxidil allows more oxygen and nutientes 
to the hair follicles. 
About its potential use in vitiligo treatment, 
only the study of Srinivas et al. reports its efficacy. 
The authors described how the association of the 
daily use of topical 2% Minoxidil with alternate day 
PUVA, was able to induce local hyperthricosis and 
marker repigmentation in two vitiligo patients [37]. 
Unfortunately, no other studies about 
Minoxidil in vitiligo have been conduced and some 
clinical reports underline controversial results, such as 
the appearance of leucoderma after the use of the 
drug [38]. 
 
 
Minerals 
 
Since the discovery of the role of oxidative 
stress in the pathogenesis of vitiligo, some minerals 
with proved antioxidative effects, such as Selenium 
and Manganese, have been proposed as adjuvant 
oral therapies for the treatment of the skin disease, in 
association to more conventional therapies (e.g. 
phototherapy). Unfortunately, today only few studies 
are available on their use, in terms of both dosage 
and efficacy [39][40][41]. 
 
 
Omega-3 polyunsatured fatty acids 
 
Omega-3 fatty acids are polyunsaturated fatty 
acids, with antioxidant and anti-inflammatory 
properties. 
In medicine, they are administrated for the 
treatment of different disorders, such as 
cardiovascular diseases, rheumatoid arthritis, atopic 
diseases, neurodegenerative disorders, cognitive 
problems, and others [42][43]. They can be assumed 
with different foods (e.g. fish, fish and krill oils, fruits) 
or as industrial supplements. 
Recently, omega-3 fatty acids have been 
proposed for vitiligo treatment and to limit the side 
effects due to phototherapies [1]. Unfortunately, no 
data are available. 
 
Prostaglandin E2 (PGE2) 
Prostaglandin E2 is a member of 
prostaglandins, a group of hormone-like substances 
that participate in a wide range of body functions 
(e.g. uterine contraction, control of blood pressure, 
modulation of inflammation). In details, PGE2 is an 
immunomodulatory agent, capable to stimulate 
melanocytes [44]. 
In the last years, a topic gel composed by 
PGE2 has been introduced for the treatment of 
vitiliginous patients. The drug has been observed to 
be effective both used alone or in combination with 
topical corticosteroids or target nb-UVB phototherapy 
[45][46][47]. No relevant side effects have been 
described. 
 
 
Pseudocatalase 
 
In the last years, topical cream cointaning 
pseudocatalase has been proposed as a valid 
therapeuthic tool for vitiligo. The drug acts reducing 
the free radicals and improving the catalase action. 
Generally, it is applied twice a day. Better results 
seem to be achieved when pseudocatalase is 
associated to sol-therapy, UVA or nb-UVB [48][49]. 
Unfortunately, not all the research confirm this data: 
some studies underline how the use of 
pseucocatalase, used alone or associated to UVR, 
doesn’t add any beneficial [50][51]. 
 
 
Resveratrol 
 
Resveratrol is a natural phenol, with marked 
antioxidant and anti-inflammatory properties. It may be 
assumed with diet (e.g. wine, peanut, cocoa) or 
artificial supplements. Recent studies show how its 
suppletion may be useful in vitiligo treatment, also in 
association to the classical PUVA-therapy [52][52][53]. 
 
 
Soybeans 
 
Soybeans (also known as soya beans) are a 
type of legume, particularly rich in flavonoids, which 
explain how they can be used in vitiliginous patients to 
halt the oxidative stress phenomenon [1]. 
Recently, researchers have isolated by 
soybeans an oestrogen, called Genistein. Few study 
suggest how its oral and topical administration, are 
useful in reducing the cell damage by UVR, 
suggesting a possible adjuvant use of Genistein to 
phototherapy [54]. 
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Tars 
 
Tars are oily, viscous material, consisting 
mainly of hydrocarbons, produced by the destructive 
distillation of organic substances such as wood, coal, 
or peat. In past, they had been widely used for the 
topical treatment of psoriasis, both alone or in 
association to UVR. Because of their antinflammatory 
and immunosuppressive effects, tars had been also 
proposed for the treatment of vitiligo [55]. Actually 
they are not used, not only for the limited data on their 
effectiveness, but also for their toxicity and 
carcinogenic effects. 
 
 
Vitamins 
 
Vitamins are organic compounds, essential 
for the normal human growth and development, 
and for its healthy maintenance. Even if some of 
them are synthesized by the body organs, the others 
must be assumed with foods or supplements. 
Because of the beneficial effects of some 
vitamins on the skin, since long time dermatologists 
used to prescribe them for the treatment of different 
cutaneous diseases. Also for vitiliginous patients, 
some vitamins have been observed to be useful. 
Among them, there are: vitamin A, B12, C and E [56]. 
Different studies underline how an oral 
supplement of those vitamins is indicated in the 
treatment of vitiliginous patients, because of their 
antioxidant properties. Interesting are the good results 
in term of repigmentation, achieved in vitiliginous 
patients treated with phototherapy associated to oral 
vitamins C and E, which are natural photoprotectors 
[1][57]. 
 In conclusion, a part for well-documented 
effectiveness of L-phenylalanine, PGE2 and 
antioxidant agents in the treatment of vitiligo, for the 
other therapeutical approaches more investigations 
are needed. 
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